2014 Pharmaceutical manufacturing Physicians 
World of DTC Marketing
AUGUST 12, 2022
Data were mainly accessible for smaller firms, products in some therapeutic regions, orphan drugs, first-in-class drugs, therapeutic agents that received accelerated approval, and products between 2014 and 2018. The most telling data on a disconnect between drug prices and research costs has received almost no public attention.
pharmaphorum
OCTOBER 26, 2022
The status isn’t awarded lightly and Chiesi is the largest pharmaceutical manufacturer to be named a B Corp. “We This design will enable physicians to take more informed and robust treatment decisions than in most other cases,” Chiesi said. He serves as a Board Member on the Board of the Chiesi Group.
Expert insights. Personalized for you.
255 
Let's personalize your content